Cargando…

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide. Renin-angiotensin system (RAS) inhibitors are the first-line treatment for diabetic patients with hypertension. However, whether RAS inhibitors prevent the development of DKD remains controversial. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazaki, Hiroki, Babazono, Akira, Nishi, Takumi, Maeda, Toshiki, Imatoh, Takuya, Ichiba, Masayoshi, Une, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567802/ https://www.ncbi.nlm.nih.gov/pubmed/26362195 http://dx.doi.org/10.1186/s40360-015-0024-y

Ejemplares similares

Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes
por: Nishi, Takumi, et al.
Publicado: (2015)

Risk of hospitalization for diabetic macrovascular complications and in‐hospital mortality with irregular physician visits using propensity score matching
por: Nishi, Takumi, et al.
Publicado: (2013)

Surveillance of First-Generation H1-Antihistamine Use for Older Patients with Dementia in Japan: A Retrospective Cohort Study
por: Maeda, Toshiki, et al.
Publicado: (2018)

Association between income levels and irregular physician visits after a health checkup, and its consequent effect on glycemic control among employees: A retrospective propensity score‐matched cohort study
por: Nishi, Takumi, et al.
Publicado: (2019)

Impact of the 2014 coinsurance rate revision for the elderly on healthcare resource utilization in Japan
por: Nishi, Takumi, et al.
Publicado: (2021)

Investigation of the Existence of Supplier-Induced Demand in use of Gastrostomy Among Older Adults: A Retrospective Cohort Study
por: Maeda, Toshiki, et al.
Publicado: (2016)

Investigation into the causes of indwelling urethral catheter implementation and its effects on clinical outcomes and health care resources among dementia patients with pneumonia: A retrospective cohort study
por: Maeda, Toshiki, et al.
Publicado: (2016)

Regional differences in performance of bone marrow transplantation, care-resource use and outcome for adult T-cell leukaemia in Japan
por: Maeda, Toshiki, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Effects of Low Body Mass Index and Smoking on All-cause Mortality among Middle-aged and Elderly Japanese
por: Miyazaki, Motonobu, et al.
Publicado: (2007)

Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis
por: Cho, Miseung, et al.
Publicado: (2023)

Management of renin-angiotensin-aldosterone inhibitors and other antihypertensives and their clinical effects on pre-anesthesia blood pressure
por: Balcı, Eda, et al.
Publicado: (2022)

The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia
por: Maeda, Toshiki, et al.
Publicado: (2015)

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS
por: Manoharan, Sivananthan, et al.
Publicado: (2017)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
por: Bezabih, Yihienew M., et al.
Publicado: (2021)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
por: Goel, Mishita, et al.
Publicado: (2020)

The role of renin angiotensin system inhibition in kidney repair
por: van der Meer, Irene M, et al.
Publicado: (2010)

Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney
por: Jang, In-Ae, et al.
Publicado: (2018)

Do inhibitors of the renin–angiotensin system prevent chronic kidney disease?
por: Rayner, Brian
Publicado: (2010)

Sympathoexcitation Associated with Renin-Angiotensin System in Metabolic Syndrome
por: Kishi, Takuya, et al.
Publicado: (2013)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies
por: Kai, Hisashi, et al.
Publicado: (2021)

Molecular remodeling of the renin-angiotensin system after kidney transplantation
por: Antlanger, Marlies, et al.
Publicado: (2017)

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
por: Kovarik, Johannes J., et al.
Publicado: (2019)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Inhibition of the renin-angiotensin system during fetal kidney development
por: Park, Eujin
Publicado: (2020)

Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy
por: Okamoto, Kohei, et al.
Publicado: (2021)

Renin-Angiotensin System Inhibitors Reduce Serum Asymmetric Dimethylarginine Levels and Oxidative Stress in Normotensive Patients with Chronic Kidney Disease
por: Fujii, Hideki, et al.
Publicado: (2014)

Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
por: Cahova, Monika, et al.
Publicado: (2021)

Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
por: Torigoe, Kenta, et al.
Publicado: (2022)

Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice
por: Tsuji, Takumi, et al.
Publicado: (2022)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease
por: Saigusa, Takamitsu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2ej4193h4fa9c7mk2eo5k578rv